NASDAQ:CADL

Candel Therapeutics Stock Predictions

etoro logo Buy CADL
*Your capital is at risk
$8.80
+0.380 (+4.51%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CADL Prediction Chart

CADL Predictions History

Latest community submissions for CADL.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 24, 2024 $5.54 -6.31% $6.05 X 91.52% 0
Apr 24, 2024 $5.68 -3.95% $6.05 X 93.83% 0
Apr 24, 2024 $6.10 +10.11% $6.05 V 99.17% 3
Apr 23, 2024 $5.93 +6.96% $5.91 V 99.73% 5
Apr 23, 2024 $5.78 +4.35% $5.91 V 97.82% 1
Apr 23, 2024 $6.10 +17.99% $5.91 V 96.79% 1
Dec 6, 2023 $0.83 +5.90% $0.89 V 92.81% 1
Dec 6, 2023 $0.81 +3.68% $0.89 V 90.87% 1
AlexVel AlexVel Pro
Dec 6, 2023 $0.769 -1.42% $0.89 X 86.40% 0
AlexVel AlexVel Pro
Dec 5, 2023 $0.91 +1.25% $0.780 X 83.18% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CADL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE